Aerovate Therapeutics, Inc. (Aerovate), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease, today announced the appointment of veteran biotechnology leader Timothy Noyes as Chief Executive Officer. Mr. Noyes was also elected to the Aerovate Board of Directors in April 2021.
Aerovate Therapeutics, Inc. (Aerovate), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease, today announced the appointment of veteran biotechnology leader Timothy Noyes as Chief Executive Officer. Mr. Noyes was also elected to the Aerovate Board of Directors in April 2021.